echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > European Radiology: Effects of gadolinium-based contrast agents on automated measures of brain atrophy in patients with multiple sclerosis

    European Radiology: Effects of gadolinium-based contrast agents on automated measures of brain atrophy in patients with multiple sclerosis

    • Last Update: 2022-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Studies have shown that gray matter (GM) atrophy measured on MRI in patients with multiple sclerosis (MS) reflects irreversible axonal loss and neurodegenerative changes in the central nervous system


    Studies have shown that gray matter (GM) atrophy measured on MRI in patients with multiple sclerosis (MS) reflects irreversible axonal loss and neurodegenerative changes in the central nervous system


    There are many methods and software currently available to measure GM atrophy


    Because of the high tissue contrast of non- enhanced three-dimensional (3D) T1-weighted images, brain segmentation software often uses this sequence of images for evaluation .


    The use of GBCA has increased over the past three decades


    A study published in the journal European Radiology validates volume and cortical thickness measurements using GBCA -enhanced T1-weighted images and provides guidance on how to interpret clinically relevant and commonly considered measurements .


    There was good to excellent reliability between all survey measures, with ICC ranging from 0.




    This study demonstrates that FreeSurfer can obtain reliable GM atrophy measurements from enhanced three-dimensional T1-weighted images .


    Original source :

    Ingrid Anne Lie , Emma Kerklingh , Kristin Wesnes ,et al .


    Ingrid Anne Lie Emma Kerklingh Kristin Wesnes ,et al The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis 10.
    1007/s00330-021-08405-8 10.
    1007/

    s00330-021-08405-8in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.